GENEVA, April 19 -- UNIVERSITAT ZU KOLN (Albertus-Magnus-Platz50923 Koln) filed a patent application (PCT/EP2024/078895) for "BROADLY NEUTRALIZING ANTIBODY TARGETING THE V3 GLYCAN SITE ON HIV ENV" on Oct 14, 2024. With publication no. WO/2025/078693, the details related to the patent application was published on Apr 17, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): KLEIN, Florian (Erkelenzer StraBe 850933 Koln), GIESELMANN, Lutz (Virchowstr. 3150935 Koln)
Abstract:
The present invention relates to monoclonal human antibodies or binding fragments thereof which are directed against the V3...